Haematology Archives - Page 2 of 2 - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

Haematology

03 Sep 2021
- Haematology
- Immunology
Sobi agrees $8bn takeover offer from Advent and GIC

By PBR Staff Writer

Swedish Orphan Biovitrum (Sobi) has agreed a $8bn (SEK69.4bn) takeover offer from Advent International and Singapore’s wealth fund GIC.
15 Mar 2021
Haematology
Drug Filing
Hematological Disorders
Takeda submits New Drug Application for lanadelumab in Japan

By PBR Staff Writer

Japan-based, R&D-driven Takeda Pharmaceutical Company Limited has submitted a New Drug Application (NDA) for lanadelumab to the Ministry of Health, Labour and Welfare (MHLW) in Japan.
19 Feb 2021
Hematological Disorders
Approvals
Pharmaceuticals and Healthcare
USFDA grants FTD to efanesoctocog alfa for hemophilia A treatment

By PBR Staff Writer

The U.S. Food and Drug Administration (FDA) has granted efanesoctocog alfa – earlier termed BIVV001 (rFVIIIFc-VWF-XTEN) – Fast Track Designation (FTD) for the treatment of patients suffering from hemophilia A.